# Johnson Outdoors Inc: financial statements, quarterly

JOUT · Nasdaq · CIK 788329 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Oct 2

Pages: [Overview](/companies/jout.md) · [Financials](/companies/jout/financials.md) · [Filings](/companies/jout/filings.md) · [Insiders](/companies/jout/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/jout/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-09-29) | Q1 FY2024 (2023-12-29) | Q2 FY2024 (2024-03-29) | Q3 FY2024 (2024-06-28) | Q4 FY2024 (2024-09-27) | Q1 FY2025 (2024-12-27) | Q2 FY2025 (2025-03-28) | Q3 FY2025 (2025-06-27) | Q4 FY2025 (2025-10-03) | Q1 FY2026 (2026-01-02) | Q2 FY2026 (2026-04-03) | Q3 FY2026 (2026-07-03) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [96.3](/filings/0001140361-24-049014.md) | [139](/filings/0001140361-25-045348.md) | [176](/filings/0001140361-25-045348.md) | [172](/filings/0001140361-25-045348.md) | [106](/filings/0001140361-25-045348.md) | [108](/filings/0001140361-26-004135.md) | [168](/filings/0001140361-26-019996.md) | [181](/filings/0000788329-26-000016.md) | [136](/filings/0001140361-25-045348.md) | [141](/filings/0001140361-26-004135.md) | [194](/filings/0001140361-26-019996.md) | [190](/filings/0000788329-26-000016.md) |
| Cost of revenue | $m | [68.0 d](/filings/0001140361-25-045348.md) | [85.8](/filings/0001140361-25-002853.md) | [114](/filings/0001140361-25-017047.md) | [111](/filings/0001140361-25-028318.md) | [81.0 d](/filings/0001140361-25-045348.md) | [75.5](/filings/0001140361-26-004135.md) | [109](/filings/0001140361-26-019996.md) | [113](/filings/0000788329-26-000016.md) | [86.6 d](/filings/0001140361-25-045348.md) | [89.3](/filings/0001140361-26-004135.md) | [119](/filings/0001140361-26-019996.md) | [104](/filings/0000788329-26-000016.md) |
| Gross profit | $m | [28.4](/filings/0001140361-24-049014.md) | [52.9](/filings/0001140361-25-045348.md) | [61.4](/filings/0001140361-25-045348.md) | [61.8](/filings/0001140361-25-045348.md) | [24.9](/filings/0001140361-25-045348.md) | [32.2](/filings/0001140361-26-004135.md) | [58.9](/filings/0001140361-26-019996.md) | [67.9](/filings/0000788329-26-000016.md) | [49.1](/filings/0001140361-25-045348.md) | [51.6](/filings/0001140361-26-004135.md) | [75.5](/filings/0001140361-26-019996.md) | [85.9](/filings/0000788329-26-000016.md) |
| Research and development | $m | [7.5 d](/filings/0001140361-25-045348.md) | [8.1](/filings/0001140361-25-002853.md) | [8.1](/filings/0001140361-25-017047.md) | [7.3](/filings/0001140361-25-028318.md) | [7.6 d](/filings/0001140361-25-045348.md) | [7.6](/filings/0001140361-26-004135.md) | [8.1](/filings/0001140361-26-019996.md) | [7.6](/filings/0000788329-26-000016.md) | [8.9 d](/filings/0001140361-25-045348.md) | [7.9](/filings/0001140361-26-004135.md) | [8.6](/filings/0001140361-26-019996.md) | [8.7](/filings/0000788329-26-000016.md) |
| Operating income | $m | [(22.6)](/filings/0001140361-24-049014.md) | [0.0](/filings/0001140361-25-045348.md) | [(0.3)](/filings/0001140361-25-045348.md) | [(0.5)](/filings/0001140361-25-045348.md) | [(42.8)](/filings/0001140361-25-045348.md) | [(20.2)](/filings/0001140361-26-004135.md) | [4.9](/filings/0001140361-26-019996.md) | [7.3](/filings/0000788329-26-000016.md) | [(8.2)](/filings/0001140361-25-045348.md) | [(2.9)](/filings/0001140361-26-004135.md) | [10.3](/filings/0001140361-26-019996.md) | [18.3](/filings/0000788329-26-000016.md) |
| Interest expense | $m | [0.0 d](/filings/0001140361-23-056923.md) | [0.0](/filings/0001140361-24-005249.md) | [0.0](/filings/0001140361-24-024242.md) | [0.0](/filings/0001140361-25-028318.md) | [0.0 d](/filings/0001140361-25-045348.md) | [0.0](/filings/0001140361-26-004135.md) | [0.1](/filings/0001140361-26-019996.md) | [0.0](/filings/0000788329-26-000016.md) | [0.1 d](/filings/0001140361-25-045348.md) | [0.1](/filings/0001140361-26-004135.md) | [0.0](/filings/0001140361-26-019996.md) | [0.1](/filings/0000788329-26-000016.md) |
| Income tax | $m | [(6.1)](/filings/0001140361-24-049014.md) | [1.9](/filings/0001140361-25-045348.md) | [0.9](/filings/0001140361-25-045348.md) | [(0.7)](/filings/0001140361-25-045348.md) | [(5.4)](/filings/0001140361-25-045348.md) | [(3.6)](/filings/0001140361-26-004135.md) | [1.9](/filings/0001140361-26-019996.md) | [2.8](/filings/0000788329-26-000016.md) | [24.0](/filings/0001140361-25-045348.md) | [2.0](/filings/0001140361-26-004135.md) | [0.8](/filings/0001140361-26-019996.md) | [8.3](/filings/0000788329-26-000016.md) |
| Net income | $m | [(16.0)](/filings/0001140361-24-049014.md) | [4.0](/filings/0001140361-25-045348.md) | [2.2](/filings/0001140361-25-045348.md) | [1.6](/filings/0001140361-25-045348.md) | [(34.3)](/filings/0001140361-25-045348.md) | [(15.3)](/filings/0001140361-26-004135.md) | [2.3](/filings/0001140361-26-019996.md) | [7.7](/filings/0000788329-26-000016.md) | [(29.1)](/filings/0001140361-25-045348.md) | [(3.3)](/filings/0001140361-26-004135.md) | [9.4](/filings/0001140361-26-019996.md) | [14.9](/filings/0000788329-26-000016.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: not reported

## Balance sheet

| Line item | Unit | FY2023 (2023-09-29) | Q1 FY2024 (2023-12-29) | Q2 FY2024 (2024-03-29) | Q3 FY2024 (2024-06-28) | FY2024 (2024-09-27) | Q1 FY2025 (2024-12-27) | Q2 FY2025 (2025-03-28) | Q3 FY2025 (2025-06-27) | FY2025 (2025-10-03) | Q1 FY2026 (2026-01-02) | Q2 FY2026 (2026-04-03) | Q3 FY2026 (2026-07-03) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [112](/filings/0001140361-24-049014.md) | [80.5](/filings/0001140361-25-002853.md) | [60.4](/filings/0001140361-25-017047.md) | [127](/filings/0001140361-25-028318.md) | [145](/filings/0001140361-25-045348.md) | [95.3](/filings/0001140361-26-004135.md) | [89.6](/filings/0001140361-26-019996.md) | [159](/filings/0000788329-26-000016.md) | [176](/filings/0000788329-26-000016.md) | [131](/filings/0001140361-26-004135.md) | [108](/filings/0001140361-26-019996.md) | [175](/filings/0000788329-26-000016.md) |
| Current assets | $m | [459](/filings/0001140361-24-049014.md) | [476](/filings/0001140361-25-002853.md) | [477](/filings/0001140361-25-017047.md) | [461](/filings/0001140361-25-028318.md) | [429](/filings/0001140361-25-045348.md) | [388](/filings/0001140361-26-004135.md) | [407](/filings/0001140361-26-019996.md) | [420](/filings/0000788329-26-000016.md) | [409](/filings/0000788329-26-000016.md) | [409](/filings/0001140361-26-004135.md) | [428](/filings/0001140361-26-019996.md) | [448](/filings/0000788329-26-000016.md) |
| Total assets | $m | [682](/filings/0001140361-25-045348.md) | [693](/filings/0001140361-25-002853.md) | [692](/filings/0001140361-25-017047.md) | [680](/filings/0001140361-25-028318.md) | [635](/filings/0001140361-25-045348.md) | [613](/filings/0001140361-26-004135.md) | [624](/filings/0001140361-26-019996.md) | [634](/filings/0000788329-26-000016.md) | [604](/filings/0000788329-26-000016.md) | [600](/filings/0001140361-26-004135.md) | [618](/filings/0001140361-26-019996.md) | [648](/filings/0000788329-26-000016.md) |
| Current liabilities | $m | [104](/filings/0001140361-24-049014.md) | [104](/filings/0001140361-25-002853.md) | [109](/filings/0001140361-25-017047.md) | [99.3](/filings/0001140361-25-028318.md) | [90.4](/filings/0001140361-25-045348.md) | [91.7](/filings/0001140361-26-004135.md) | [105](/filings/0001140361-26-019996.md) | [106](/filings/0000788329-26-000016.md) | [105](/filings/0000788329-26-000016.md) | [108](/filings/0001140361-26-004135.md) | [123](/filings/0001140361-26-019996.md) | [133](/filings/0000788329-26-000016.md) |
| Total liabilities | $m | [182](/filings/0001140361-24-049014.md) | [189](/filings/0001140361-25-002853.md) | [192](/filings/0001140361-25-017047.md) | [181](/filings/0001140361-25-028318.md) | [172](/filings/0001140361-25-045348.md) | [173](/filings/0001140361-26-004135.md) | [183](/filings/0001140361-26-019996.md) | [184](/filings/0000788329-26-000016.md) | [186](/filings/0000788329-26-000016.md) | [187](/filings/0001140361-26-004135.md) | [199](/filings/0001140361-26-019996.md) | [218](/filings/0000788329-26-000016.md) |
| Long-term debt | $m | [0.0](/filings/0001140361-24-049014.md) | [0.0](/filings/0001140361-25-002853.md) | [0.0](/filings/0001140361-25-017047.md) | [0.0](/filings/0001140361-25-028318.md) | [0.0](/filings/0001140361-25-045348.md) | [0.0](/filings/0001140361-26-004135.md) | [0.0](/filings/0001140361-26-019996.md) | [0.0](/filings/0000788329-26-000016.md) | [0.0](/filings/0000788329-26-000016.md) | [0.0](/filings/0001140361-26-004135.md) | [0.0](/filings/0001140361-26-019996.md) | [0.0](/filings/0000788329-26-000016.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [500](/filings/0001140361-24-049014.md) | [504](/filings/0001140361-25-002853.md) | [500](/filings/0001140361-25-017047.md) | [499](/filings/0001140361-25-028318.md) | [463](/filings/0001140361-25-045348.md) | [440](/filings/0001140361-26-004135.md) | [441](/filings/0001140361-26-019996.md) | [450](/filings/0000788329-26-000016.md) | [418](/filings/0000788329-26-000016.md) | [414](/filings/0001140361-26-004135.md) | [419](/filings/0001140361-26-019996.md) | [431](/filings/0000788329-26-000016.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: not reported
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-09-29) | Q1 FY2024 (2023-12-29) | Q2 FY2024 (2024-03-29) | Q3 FY2024 (2024-06-28) | Q4 FY2024 (2024-09-27) | Q1 FY2025 (2024-12-27) | Q2 FY2025 (2025-03-28) | Q3 FY2025 (2025-06-27) | Q4 FY2025 (2025-10-03) | Q1 FY2026 (2026-01-02) | Q2 FY2026 (2026-04-03) | Q3 FY2026 (2026-07-03) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(3.5) d](/filings/0001140361-25-045348.md) | [(33.7)](/filings/0001140361-25-002853.md) | [(18.1) d](/filings/0001140361-25-017047.md) | [73.7 d](/filings/0001140361-25-028318.md) | [19.1 d](/filings/0001140361-25-045348.md) | [(36.9)](/filings/0001140361-26-004135.md) | [(1.7) d](/filings/0001140361-26-019996.md) | [71.4 d](/filings/0000788329-26-000016.md) | [23.4 d](/filings/0001140361-25-045348.md) | [(38.4)](/filings/0001140361-26-004135.md) | [(12.3) d](/filings/0001140361-26-019996.md) | [77.7 d](/filings/0000788329-26-000016.md) |
| Capital expenditure | $m | [3.2 d](/filings/0001140361-25-045348.md) | [5.0](/filings/0001140361-25-002853.md) | [5.2 d](/filings/0001140361-25-017047.md) | [6.2 d](/filings/0001140361-25-028318.md) | [5.6 d](/filings/0001140361-25-045348.md) | [4.1](/filings/0001140361-26-004135.md) | [3.3 d](/filings/0001140361-26-019996.md) | [4.4 d](/filings/0000788329-26-000016.md) | [4.1 d](/filings/0001140361-25-045348.md) | [4.3](/filings/0001140361-26-004135.md) | [6.2 d](/filings/0001140361-26-019996.md) | [5.9 d](/filings/0000788329-26-000016.md) |
| Dividends paid | $m | [3.1 d](/filings/0001140361-25-045348.md) | [3.3](/filings/0001140361-25-002853.md) | [3.4 d](/filings/0001140361-25-017047.md) | [3.4 d](/filings/0001140361-25-028318.md) | [3.4 d](/filings/0001140361-25-045348.md) | [3.4](/filings/0001140361-26-004135.md) | [3.4 d](/filings/0001140361-26-019996.md) | [3.4 d](/filings/0000788329-26-000016.md) | [3.4 d](/filings/0001140361-25-045348.md) | [3.4](/filings/0001140361-26-004135.md) | [3.4 d](/filings/0001140361-26-019996.md) | [3.4 d](/filings/0000788329-26-000016.md) |
| Share repurchases | $m | [(0.5) d](/filings/0001140361-25-045348.md) | [0.2](/filings/0001140361-25-002853.md) | [0.0 d](/filings/0001140361-25-017047.md) | [0.0 d](/filings/0001140361-25-028318.md) | [0.2 d](/filings/0001140361-25-045348.md) | [0.1](/filings/0001140361-26-004135.md) | [0.0 d](/filings/0001140361-26-019996.md) | [0.0 d](/filings/0000788329-26-000016.md) | [0.0 d](/filings/0001140361-25-045348.md) | [0.1](/filings/0001140361-26-004135.md) | [0.0 d](/filings/0001140361-26-019996.md) | [0.0 d](/filings/0000788329-26-000016.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2022-12-30) | Q2 FY2023 (2023-03-31) | Q3 FY2023 (2023-06-30) | Q1 FY2024 (2023-12-29) | Q2 FY2024 (2024-03-29) | Q3 FY2024 (2024-06-28) | Q1 FY2025 (2024-12-27) | Q2 FY2025 (2025-03-28) | Q3 FY2025 (2025-06-27) | Q1 FY2026 (2026-01-02) | Q2 FY2026 (2026-04-03) | Q3 FY2026 (2026-07-03) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [10.2](/filings/0001140361-24-005249.md) | [10.2](/filings/0001140361-24-024242.md) | [10.2](/filings/0001140361-24-035733.md) | [10.2](/filings/0001140361-25-002853.md) | [10.2](/filings/0001140361-25-017047.md) | [10.2](/filings/0001140361-25-028318.md) | [10.3](/filings/0001140361-26-004135.md) | [10.3](/filings/0001140361-26-019996.md) | [10.3](/filings/0000788329-26-000016.md) | [10.3](/filings/0001140361-26-004135.md) | [10.4](/filings/0001140361-26-019996.md) | [10.4](/filings/0000788329-26-000016.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:24 ET. No prices; not investment advice.